Upper-extremity impairment after stroke remains a major therapeutic challenge and a target of neuromodulation treatment efforts. In previous study, Vagus nerve stimulation was constricted to patients 9 months after stroke. In this randomized phase I trial, we would apply vagus nerve stimulation in an early stage (\<6 month) and observe its theraputic effect on motor function after ischaemic Stroke.We hypothesized that the early stimulation could be safe and more beneficial compared to stimulation in late stage.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
100
Device implantation was done under general anaesthesia. A horizontal neck crease incision was created left of the midline at the level of the cricoid cartilage. After the vagus nerve was identified, the stimulation lead was wrapped around the vagus nerve. The lead was then tunnelled subcutaneously to the pulse generator device which was contained in a subcutaneous pocket in the pectoral region.
Device implantation was done under general anaesthesia. A horizontal neck crease incision was created left of the midline at the level of the cricoid cartilage. After the vagus nerve was identified, the stimulation lead was wrapped around the vagus nerve. The lead was then tunnelled subcutaneously to the pulse generator device which was contained in a subcutaneous pocket in the pectoral region
Qilu Hospital of Shandong University
Jinan, Shandong, China
RECRUITINGFM-UE scores between early and late VNS
The outcomes includes each participant's Fugl-Meyer assessment scale (FM-UE) scores for each monthly visit. FM-UE scores range from 0 to 100 and the higher scores indicated better outcome of movement.
Time frame: 12 months after device implantation
Arm Motor Ability Test (AMAT) between early and late VNS
The outcomes includes each participant's the Arm Motor Ability Test (AMAT) for each monthly visit. AMAT scores range from 0 to 57 and the higher scores indicated better outcome of movement.
Time frame: 12 months after device implantation
the Nine-Hole Peg Test between early and late VNS
The outcomes includes each participant's the Nine-Hole Peg Test for each monthly visit.
Time frame: 12 months after device implantation
the Bilateral Box and Block Test between early and late VNS
The outcomes includes each participant's the Bilateral Box and Block Test for each monthly visit.
Time frame: 12 months after device implantation
Short Form Health Survey (SF-12) between early and late VNS
The outcomes includes each participant's score of Short Form Health Survey (SF-12) for each monthly visit. SF-12 scores range from 0 to 60 and the higher scores indicated better outcome of movement.
Time frame: 12 months after device implantation
the EuroQol Five Dimensions Questionnaire (EQ-5D) between early and late VNS
The outcomes includes each participant's score of the EuroQol (EQ-5D) scores range from 0 to 36 for each monthly visit.
Time frame: 12 months after device implantation
safety and feasibility of early and late VNS
The incidence of adverse events including hemorrhages, infections, deaths or major perioperative complications during the study
Time frame: 12 months after device implantation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.